Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04254692 · ClinicalTrials.gov registry record · Phase 4
Optimizing Recovery in Abdominoplasty
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT04254692: Clinical Trial Phase 4 study, sponsored by University of Wisconsin, Madison.
NCT04254692 is a Phase 4 study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 2 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04254692, a Phase 4 study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
The overall purpose of this study is to evaluate the analgesic efficacy of liposomal bupivacaine in optimizing pain control, minimizing the risk of postoperative nausea and vomiting (PONV), and improving recovery after abdominoplasty. This will be done by comparing intraoperative abdominal wall and incisional injection of bupivacaine to bupivacaine plus liposomal bupivacaine in 46 participants 18 years and older undergoing elective abdominoplasty. This will be studied using pain assessments, validated surveys, medication logs and review of medical records.
Primary Outcome
Amount of opioids used postoperatively, measured in morphine equivalents
Interventions
- OTHER Standard of care
- DRUG Liposomal bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-01-05 |
| Est. Completion | 2021-01-21 |
| Phase | Phase 4 |
Why NCT04254692 stopped before completion
NCT04254692 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of care is the first listed.
NCT04254692 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04254692 about?
NCT04254692 is a clinical study titled "Optimizing Recovery in Abdominoplasty". The overall purpose of this study is to evaluate the analgesic efficacy of liposomal bupivacaine in optimizing pain control, minimizing the risk of postoperative nausea and vomiting (PONV), and improving recovery after abdominoplasty. This will be done by comparing intraoperative abdominal wall and ...
What is the current status of trial NCT04254692?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2021-01-05. Estimated completion is 2021-01-21.
What interventions are being tested in trial NCT04254692?
The interventions under investigation include: Standard of care (OTHER), Liposomal bupivacaine (DRUG).
Who is sponsoring clinical trial NCT04254692?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04254692's enrollment target sits among peer trials
2 1998th of 2000 higher than 1 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI